Latest North America News

Transurban advances a major upgrade to the I-95 Express Lanes, aiming to add 120 new lane miles and extend the corridor through Fredericksburg, targeting financial close by 2029.

Ioneer Ltd has been conditionally awarded a long-term land lease by the U.S. Army to establish a critical boron processing facility at the Tooele Army Depot in Utah, marking a significant step in securing domestic defense supply chains.

Control Bionics has locked in $9.5 million through a discounted share placement, complemented by a $0.5 million Share Purchase Plan, to back its commercial growth and technology development.

Australian Rare Earths (ASX: AR3) has announced a maiden Ore Reserve of 26 million tonnes at 920 ppm TREO for its Koppamurra Rare Earths Project, underpinned by a robust Pre-Feasibility Study delivering an A$858 million post-tax NPV and a rapid payback of less than one year.

SunRice reported a 4% rise in net profit after tax for FY26 to $73.3 million, maintaining an 8% EBITDA margin despite a 2.5% revenue decline. The company declared a record fully franked dividend of 70 cents per share but expects FY27 profit to fall amid a smaller Australian rice crop.

Corporate Travel Management (ASX:CTD) has pushed back its FY25 and 1HFY26 financial statements to August 2026 due to intertwined UK customer remediation, financing negotiations, and audit complexities, while signalling significant goodwill impairments across multiple regions.

Tourism Holdings Limited has received a fresh non-binding indicative offer from a credible strategic buyer at NZ$3.30 to NZ$3.40 per share, while continuing negotiations with the BGH Consortium over due diligence access.

EROAD Limited reported stable FY26 revenue of NZD 195 million amid a $134.7 million North American impairment, unveiling a strategic reset centred on ANZ growth and its expanding electronic Road User Charges platform.

Transurban Group (ASX: TCL) declared a 35-cent unfranked distribution per stapled security for the six months ending 30 June 2026, payable in August with no approvals required.

EV Resources has validated a flotation-led processing route at its Tecomatlán Plant, achieving 81.1% antimony recovery and concentrate grades up to 62.9% Sb, enabling a low-CAPEX upgrade and a compressed production timeline.

Canadian Phosphate (ASX: CP8) secured $5.2 million through a rights issue and follow-on placement, positioning itself to accelerate exploration and development across key projects in Canada and the US.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.